GLP-1RA reduces risk of CV events associated with overweight and obesity

3' education - Nov. 11, 2023 - Michael Lincoff, MD - Cleveland, OH, USA

Educational information

This video was recorded during the AHA Scientific Sessions 2023 in Philadelphia, PA, USA.

Faculty

Michael Lincoff, MD is an interventional cardiologist and Vice Chairman for Research of the Department of Cardiovascular Medicine at the Cleveland Clinic in Cleveland, OH, USA. He is also the Director of the Cleveland Clinic Coordinating Center for Clinical Research.

Disclosures

This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.

Read a summary of the SELECT trial

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.